MedPath

Effect of supplementation in treatment of patients with diabetic foot ulcer

Phase 2
Conditions
With peripheral circulatory complications
E14.5
Diabetic foot.
Registration Number
IRCT201612225623N96
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients with diabetic foot ulcer
Aged 40 to 85 years

Exclusion Criteria

Pregnant and breastfed patients
Taking magnesium,multivitamin-mineral and antioxidant supplements and anti-inflammatory agents
Patients with history of diseases which influence the development of diabetic foot ulcer including chronic trauma

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Healing of diabetic foot ulcer (Decrease of the wound size relative to original size: ulcer length (cm), ulcer width (cm), Ulcer depth (cm)). Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Ruler.;Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath